The case for low dose diuretic therapy

Norman M Kaplan

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Diuretics remain the most popular antihypertensive agents in the US. Nonetheless, their use over the past 5 years has been falling progressively in large part because of major concerns about their multiple metabolic side effects which have been blamed for the inability to document a significant reduction in coronary disease in the multiple clinical trials wherein they have been the primary agent.1 The litany of these multiple side effects have recently been expanded by the addition of the worsening of insulin resistance.

Original languageEnglish (US)
Pages (from-to)970-971
Number of pages2
JournalAmerican Journal of Hypertension
Issue number12
StatePublished - Dec 1991

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'The case for low dose diuretic therapy'. Together they form a unique fingerprint.

Cite this